Monday, March 27, 2023
News Media Empire
  • About Us
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Home
  • World News
  • Politics
  • Business & Economy
  • Money
  • Science & Tech
  • Opinion
  • Lifestyle
  • Health
  • Sports
  • Entertainment
  • Crypto
No Result
View All Result
  • Home
  • World News
  • Politics
  • Business & Economy
  • Money
  • Science & Tech
  • Opinion
  • Lifestyle
  • Health
  • Sports
  • Entertainment
  • Crypto
No Result
View All Result
News Media Empire
No Result
View All Result
Home Health

Novavax seeks WHO approval for emergency listing of COVID-19 vaccine – National | Globalnews.ca

September 23, 2021
in Health
0
Novavax seeks WHO approval for emergency listing of COVID-19 vaccine - National | Globalnews.ca
0
SHARES
Share on FacebookShare on TwitterShare on RedditShare on Whatsapp


Novavax Inc and its partner Serum Institute of India have applied to the World Health Organization for an emergency use listing of Novavax’s COVID-19 vaccine, potentially clearing the way for the shot to ship to many poorer countries, the company said on Thursday.

Novavax has been prioritizing regulatory submissions to low- and middle-income countries after falling behind in the race for authorization in the United States and Europe, which have already vaccinated most of their residents.

Get Free Advertise Coin

Read more:
Novavax starts early trials for combined flu and COVID-19 vaccine

A WHO listing would allow Novavax to ship to multiple developing nations that rely on WHO guidance for their regulatory decisions.

It would also allow Novavax to begin distributing shots through the COVAX facility, which aims to provide equitable access to COVID-19 vaccines for low- and middle-income countries.

Story continues below advertisement

Novavax has already submitted regulatory documents to countries including India, the Philippines and Indonesia.


Click to play video: 'Coronavirus: Trudeau discusses role of Novavax, domestic vaccine production in Canada’s rollout plan'






1:31
Coronavirus: Trudeau discusses role of Novavax, domestic vaccine production in Canada’s rollout plan


Coronavirus: Trudeau discusses role of Novavax, domestic vaccine production in Canada’s rollout plan – Feb 2, 2021

Novavax shares were up more than 10% in morning trading following the announcement.

Novavax and India’s Serum Institute, the world’s largest vaccine producer, have together committed to providing more than 1.1 billion doses to the COVAX facility.

COVAX has distributed fewer than 300 million shots to poorer nations, a fraction of the roughly 6 billion shots experts say are needed.

The United States earlier this week said it was committing an additional 500 million vaccines made by Pfizer Inc to COVAX, bringing its total contribution to more than 1 billion shots.


Click to play video: 'Coronavirus: Production of Novavax COVID-19 vaccines in Canada still months away, Champagne says'






1:22
Coronavirus: Production of Novavax COVID-19 vaccines in Canada still months away, Champagne says


Coronavirus: Production of Novavax COVID-19 vaccines in Canada still months away, Champagne says – Feb 2, 2021

Novavax had previously said it would apply for WHO authorization in August, marking a slight delay in the filing. It expects to file for regulatory authorization in the United States and European Union in the fourth quarter of 2021.

Story continues below advertisement

Novavax’s COVID-19 vaccine production ramp-up has been fraught with delays and it is unclear how many Novavax shots will be available for the COVAX facility this year. Novavax said in August it was aiming to produce 100 million shots monthly by the end of the third quarter.

Read more:
Novavax says large study shows COVID-19 vaccine 90.4% effective

The Novavax shot is a protein-based vaccine, and was shown to be more than 90% effective, including against a variety of concerning variants of the coronavirus in a large, late-stage U.S.-based clinical trial.

Early studies suggest Novavax is effective at protecting against the contagious Delta variant of COVID-19, which has become dominant in many countries.

— Reporting by Manas Mishra and Leroy Leo in Bengaluru


View link »









Source link

Tags: CanadaCoronavirusCOVIDCOVID-19 VaccineHealthNewsnovavaxnovavax covid vaccinenovavax emergency usenovavax who approvalWHOWorldWorld Health Organization
Previous Post

Rugby World Cup winner Thompson pledges to donate brain for head trauma research | Sport

Next Post

Canadian supermodel Linda Evangelista says cosmetic procedure left her ‘brutally disfigured’

Related Posts

How an autism diagnosis helped this resident doctor find her place in medicine | CBC Radio
Health

How an autism diagnosis helped this resident doctor find her place in medicine | CBC Radio

March 26, 2023
Bird flu’s momentum in Canada worries experts: ‘Potential to become a pandemic’ - National | Globalnews.ca
Health

Bird flu’s momentum in Canada worries experts: ‘Potential to become a pandemic’ – National | Globalnews.ca

March 25, 2023
Cosmetic brands may have to disclose fragrance ingredients — a welcome change for Canadians with allergies | CBC News
Health

Cosmetic brands may have to disclose fragrance ingredients — a welcome change for Canadians with allergies | CBC News

March 24, 2023
Next Post
Canadian supermodel Linda Evangelista says cosmetic procedure left her 'brutally disfigured'

Canadian supermodel Linda Evangelista says cosmetic procedure left her 'brutally disfigured'

Dr Yussuf Saloojee says tobacco companies are adept at using jobs and taxes to fight control efforts.

Cost to health far more than R12bn in taxes tobacco generates, says health expert | Fin24

U.S. icebreaker gap with Russia a growing concern as Arctic ‘cold war’ heats up

U.S. icebreaker gap with Russia a growing concern as Arctic ‘cold war’ heats up

Discussion about this post

AdvertiseCoin ADCO Get Now Free
News Media Empire

Newsmediaempire is an online news source that provides the latest news and other information about everything that you must need to know. It publishes news related to various fields like world, business, sports, politics, tech, health, lifestyle, and other different exclusive stories.

Let's connect!

Categories

  • Business & Economy
  • Crypto
  • Entertainment
  • Health
  • Lifestyle
  • Money
  • Opinion
  • Politics
  • Science & Tech
  • Sports
  • World News

Recent News

  • FDIC: First Citizens Bank to acquire Silicon Valley Bank March 27, 2023
  • Max Verstappen accused of "concocting" problem at Red Bull in Sergio Perez fight March 27, 2023
  • The brand that’s too cool to be mispronouncing March 27, 2023

Join Our Newsletter!

    • About Us
    • Contact
    • Privacy Policy
    • Terms & Conditions

    newsmediaempire.com © 2021 All rights reserved.

    No Result
    View All Result
    • About Us
    • Contact
    • Home 1
    • Home 2
    • Home 3
    • Privacy Policy
    • Random
    • Sample Page
    • Terms & Conditions

    newsmediaempire.com © 2021 All rights reserved.

    en English
    ar Arabicbg Bulgarianzh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianpt Portugueseru Russianes Spanish
    This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.